Find therapies in clinical trials near you – page 69

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Study of MDNA11 Alone or with Pembrolizumab for Patients with Advanced Solid Tumors

Study of MDNA11 Alone or with Pembrolizumab for Patients with Advanced Solid Tumors

Study on Datopotamab Deruxtecan and Drug Combination for Patients with Advanced or Metastatic Endometrial, Gastric, Prostate, Ovarian, Colorectal, Urothelial, and Biliary Tract Cancers

Study on the Safety and Effects of Sparsentan for Children with Proteinuric Kidney Diseases

Study on the Safety and Effects of Sparsentan for Children with Proteinuric Kidney Diseases

Study on Efgartigimod for Children Aged 2-17 with Generalized Myasthenia Gravis

Study on Efgartigimod for Children Aged 2-17 with Generalized Myasthenia Gravis

Study on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer

Study on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer

Study on the Effects of Iptacopan in Patients with Generalized Myasthenia Gravis

Study on the Effects of Iptacopan in Patients with Generalized Myasthenia Gravis

Study on the Effectiveness and Safety of Vedolizumab for Children with Chronic Pouchitis Using a Drug Combination

Study on the Effectiveness and Safety of Vedolizumab for Children with Chronic Pouchitis Using a Drug Combination

Study on the Long-Term Safety of Aficamten (CK-3773274) for Patients with Symptomatic Hypertrophic Cardiomyopathy

Study on the Long-Term Safety of Aficamten (CK-3773274) for Patients with Symptomatic Hypertrophic Cardiomyopathy

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease

Study on the Safety of CA-4948 and Ibrutinib for Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Study on the Safety of CA-4948 and Ibrutinib for Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Study of Teclistamab and Lenalidomide as Maintenance Treatment for Newly Diagnosed Multiple Myeloma Patients After Stem Cell Transplantation

Study of Teclistamab and Lenalidomide as Maintenance Treatment for Newly Diagnosed Multiple Myeloma Patients After Stem Cell Transplantation